Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Vincenzo Abrignani"'
Publikováno v:
Monaldi Archives for Chest Disease, Vol 80, Iss 3 (2015)
Robust evidence exists on the efficacy of traditional anticoagulant oral therapy in the prevention of thrombo-embolic risk in patients with non valvular atrial fibrillation, but fears and concerns of hemorrhagic events for the physicians and logistic
Externí odkaz:
https://doaj.org/article/31bf4c0f4d8a49798f6328fb941d2c67
Autor:
Annabella Braschi, Rosalia Lo Presti, Maurizio Giuseppe Abrignani, Vincenzo Abrignani, Marcello Traina
Publikováno v:
International Journal of Food Sciences and Nutrition. 74:3-21
The impact of phytochemicals, as green tea catechins, on body composition measures has become a relevant topic as ongoing epidemiological evidence suggests their potential role in weight loss. Although catechins have been shown to modulate fat and en
Autor:
Maurizio Giuseppe, Abrignani, Alberto, Lombardo, Annabella, Braschi, Nicolò, Renda, Vincenzo, Abrignani, Renzo M, Lombardo
Publikováno v:
World Journal of Cardiology. 14:576-598
Since 2010, the European Society of Cardiology has extended prescription criteria for oral antithrombotic therapy (OAT) in atrial fibrillation (AF). Direct oral anticoagulants (DOACs) were upgraded from an IIAa recommendation in 2012 to an IA in 2016
Autor:
Maurizio Giuseppe Abrignani, Alberto Lombardo, Annabella Braschi, Nicolò Renda, Vincenzo Abrignani
Publikováno v:
World journal of cardiology. 14(3)
Classical risk factors only partially account for variations in cardiovascular disease incidence; therefore, also other so far unknown features, among which meteorological factors, may influence heart diseases (mainly coronary heart diseases, but als
Autor:
Maurizio Giuseppe Abrignani, Annabella Braschi, Giuseppe Francavilla, Vincenzo Abrignani, Vincenzo Cristian Francavilla
Publikováno v:
International journal of clinical practice. 71(5)
SummaryBackground Some electrocardiographic parameters are able to assess indirectly ventricular repolarisation homogeneity. It is consequently essential to discriminate between normal and abnormal values in clinical decision-making. Considering ther
Publikováno v:
Monaldi Archives for Chest Disease, Vol 80, Iss 3 (2015)
Robust evidence exists on the efficacy of traditional anticoagulant oral therapy in the prevention of thrombo-embolic risk in patients with non valvular atrial fibrillation, but fears and concerns of hemorrhagic events for the physicians and logistic